Table 1.
Characteristics of the study population of incarcerated HCV-infected persons (n = 217), Vermont, December 2018–June 2020 a
| Characteristic | No. (%) b |
|---|---|
| Median age (range) [IQR], y | 35 (18-73) [30-43] |
| Male | 193 (89) |
| Detainer status c | 71 (33) |
| Cirrhosis | 20 (9) |
| Hepatitis B virus infection d | 1 (<1) |
| HIV | 0 |
| Opioid use disorder | 164 (76) |
| Medication-assisted treatment for opioid use disorder | |
| Yes | 146 (89) |
| No | 18 (11) |
| Alcohol use disorder | 31 (14) |
| Polysubstance use | 29 (13) |
| Psychiatric disorder | 145 (67) |
| Depression | 63 (43) |
| Anxiety | 54 (37) |
| Posttraumatic stress disorder | 39 (27) |
| Personality disorder | 25 (17) |
| Bipolar disorder | 20 (14) |
| Attention deficit hyperactivity disorder | 17 (12) |
| Behavior disorder | 8 (6) |
| Other | 18 (12) |
| >1 Psychiatric disorder | 79 (54) |
| Cardiovascular disease | 30 (14) |
| Pulmonary disease | 30 (14) |
| Gastroesophageal reflux disease | 35 (16) |
| Chronic kidney disease | 1 (<1) |
| Diabetes | 4 (2) |
Abbreviation: HCV, hepatitis C virus.
a
Data obtained through a retrospective, observational cohort study of all HCV-infected persons who were imprisoned in Vermont during the study period. HCV infection determined by detectable serum HCV RNA.
b
All values are number (percentage) unless otherwise indicated.
c
A detainer is an incarcerated person awaiting sentencing; the length of incarceration of such is unknown and unpredictable.
d
Serum hepatitis B virus surface antigen positive.